- Home
- BCSF vs OCUL Comparison
BCSF vs OCUL Comparison
Compare BCSF & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCSF
- OCUL
- Stock Information
- Founded
- BCSF 2015
- OCUL 2006
- Country
- BCSF United States
- OCUL United States
- Employees
- BCSF N/A
- OCUL N/A
- Industry
- BCSF Finance/Investors Services
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- BCSF Finance
- OCUL Health Care
- Exchange
- BCSF Nasdaq
- OCUL Nasdaq
- Market Cap
- BCSF 1.0B
- OCUL 957.3M
- IPO Year
- BCSF 2018
- OCUL 2014
- Fundamental
- Price
- BCSF $15.12
- OCUL $7.06
- Analyst Decision
- BCSF Hold
- OCUL Strong Buy
- Analyst Count
- BCSF 4
- OCUL 10
- Target Price
- BCSF $16.50
- OCUL $16.11
- AVG Volume (30 Days)
- BCSF 292.4K
- OCUL 1.6M
- Earning Date
- BCSF 05-05-2025
- OCUL 05-05-2025
- Dividend Yield
- BCSF 0.79%
- OCUL N/A
- EPS Growth
- BCSF N/A
- OCUL N/A
- EPS
- BCSF 1.74
- OCUL N/A
- Revenue
- BCSF $284,993,000.00
- OCUL $59,647,000.00
- Revenue This Year
- BCSF N/A
- OCUL $13.32
- Revenue Next Year
- BCSF N/A
- OCUL $13.13
- P/E Ratio
- BCSF $8.72
- OCUL N/A
- Revenue Growth
- BCSF N/A
- OCUL N/A
- 52 Week Low
- BCSF $13.20
- OCUL $4.06
- 52 Week High
- BCSF $19.21
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- BCSF 46.65
- OCUL 44.18
- Support Level
- BCSF $14.69
- OCUL $6.84
- Resistance Level
- BCSF $15.58
- OCUL $8.90
- Average True Range (ATR)
- BCSF 0.38
- OCUL 0.47
- MACD
- BCSF 0.07
- OCUL -0.11
- Stochastic Oscillator
- BCSF 50.00
- OCUL 10.71
About BCSF Bain Capital Specialty Finance Inc.
Bain Capital Specialty Finance Inc is an externally managed, closed-end, non-diversified management investment company. The company's objective is to provide risk-adjusted returns and current income to investors by investing predominantly in middle-market companies with between $10.0 million and $150.0 million in annual EBITDA. Its portfolio of investments includes First Lien Senior Secured Loan, Preferred Equity, Equity Interest, Warrants, and Second Lien Senior Secured Loan among others.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.